Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.770
+0.540 (24.22%)
At close: Jun 26, 2026, 4:00 PM EDT
2.770
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $175.49 million as of June 26, 2026. Its market cap has increased by 121.32% in one year.
Market Cap
175.49M
Enterprise Value
152.73M
1-Year Change
121.32%
Ranking
Category
Stock Price
$2.77
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $175.49M, a decrease of -66.49%. That is a compound annual growth rate of -20.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 175.49M | 145.09% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precision BioSciences | 188.10M |
| AN2 Therapeutics | 187.28M |
| Protalix BioTherapeutics | 185.31M |
| Korro Bio | 183.17M |
| LENZ Therapeutics | 182.48M |
| OnKure Therapeutics | 181.78M |
| Acumen Pharmaceuticals | 170.46M |
| Milestone Pharmaceuticals | 168.70M |